SNS 301 companion diagnostic - Sensei Biotherapeutics
Latest Information Update: 28 Mar 2022
At a glance
- Originator Sensei Biotherapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Head and neck cancer; Myelodysplastic syndromes; Prostate cancer
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for clinical-Phase-Unknown development in Head-and-neck-cancer(Diagnosis) in Unknown
- 28 Mar 2022 No recent reports of development identified for clinical-Phase-Unknown development in Myelodysplastic-syndromes(Diagnosis) in Unknown
- 28 Mar 2022 No recent reports of development identified for phase-I development in Prostate-cancer(Diagnosis) in USA